3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Barrett Esophagus
13
Esophageal Neoplasms
7
Rectal Neoplasms
6
Colorectal Neoplasms
6
Adenocarcinoma Of Esophagus
6
Nasopharyngeal Carcinoma
5
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Polyps
3
Lung Neoplasms
3
Precancerous Conditions
2
Pathologic Complete Response
2
Hyperplasia
2
Gastroesophageal Reflux
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Adenomatous Polyposis Coli
2
Adenocarcinoma
2
Urogenital Neoplasms
1
Upper Tract Urothelial Carcinoma
1
Thyroid Neoplasms
1
Stomach Ulcer
1
Stomach Diseases
1
Recurrence
1
Polyposis, Gastric
1
Ovarian Neoplasms
1
Nasopharyngeal Neoplasms
1
Metaplasia
1
Interventions
Carboplatin
7
Trastuzumab
6
Docetaxel
5
pembrolizumab
4
Paclitaxel
4
Oxaliplatin
4
Fluorouracil
4
Cytarabine
4
Cyclophosphamide
4
Azacitidine
4
pertuzumab
3
Radiotherapy
3
Epirubicin
3
Cisplatin
3
Chemoradiotherapy
3
Capecitabine
3
venetoclax
2
toripalimab
2
sargramostim
2
olaparib
2
durvalumab
2
cc-486
2
Tretinoin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Observation
2
Monatide (IMS 3015)
2
Metformin
2
Leucovorin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Pathologic Complete Response
×
Endoscopy
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled
NCT03125343
2023-11-07
WoW
Sahlgrenska University Hospital
Phase NA
Recruiting
400 enrolled